Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

NR2F2 controls malignant squamous cell carcinoma state by promoting stemness and invasion and repressing differentiation V

ABSTRACT: NR2F2 controls malignant squamous cell carcinoma state by promoting stemness and invasion and repressing differentiation V

PROVIDER: PRJNA733354 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR15963386_1.fastq.gz	Fastqsanger.gz
	SRR15963386_2.fastq.gz	Fastqsanger.gz
	SRR15963387_1.fastq.gz	Fastqsanger.gz
	SRR15963387_2.fastq.gz	Fastqsanger.gz
	SRR15963388_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 16

Similar Datasets

NR2F2 controls malignant squamous cell carcinoma state by promoting stemness and invasion and repressing differentiation IV

Project description:The non-genetic mechanisms required to sustain malignant tumor state are poorly understood. During the transition from benign tumors to malignant carcinoma, tumor cells need to repress differentiation and acquire invasive features. Using transcriptional profiling of cancer stem cells (CSC) from benign tumors and malignant skin squamous cell carcinoma (SCC), we identified the nuclear receptor NR2F2 as uniquely expressed in malignant SCC. Using genetic gain- and loss-of-function in vivo, we show that NR2F2 is essential for promoting the malignant tumor state by controlling tumor stemness and maintenance in mouse and human SCC. We demonstrate that NR2F2 promotes tumor cell proliferation, epithelial-mesenchymal transition (EMT) and invasive features, while repressing tumor differentiation and immune cell infiltration by regulating a common transcriptional program in mouse and human SCCs. Altogether, we identify NR2F2 as a key regulator of malignant CSC functions that promotes tumor renewal and restricts differentiation to sustain malignant tumor state.

2021-09-27 | GSE175724 | GEO

NR2F2 controls malignant squamous cell carcinoma state by promoting stemness and invasion and repressing differentiation V

2021-09-27 | GSE175726 | GEO

NR2F2 controls malignant squamous cell carcinoma state by promoting stemness and invasion and repressing differentiation III

2021-09-27 | GSE164602 | GEO

NR2F2 controls malignant squamous cell carcinoma state by promoting stemness and invasion and repressing differentiation II

2021-09-27 | GSE164597 | GEO

NR2F2 is an essential regulator of malignant tumor state by promoting tumor stemness, invasion and repressing differentiation I

2021-09-29 | GSE164592 | GEO

NR2F2 controls malignant squamous cell carcinoma state by promoting stemness and invasion and repressing differentiation

Project description:NR2F2 controls malignant squamous cell carcinoma state by promoting stemness and invasion and repressing differentiation

| PRJNA691316 | ENA

NR2F2 controls malignant squamous cell carcinoma state by promoting stemness and invasion and repressing differentiation III

Project description:NR2F2 controls malignant squamous cell carcinoma state by promoting stemness and invasion and repressing differentiation III

| PRJNA691322 | ENA

NR2F2 controls malignant squamous cell carcinoma state by promoting stemness and invasion and repressing differentiation II

Project description:NR2F2 controls malignant squamous cell carcinoma state by promoting stemness and invasion and repressing differentiation II

| PRJNA691305 | ENA

NR2F2 controls malignant squamous cell carcinoma state by promoting stemness and invasion and repressing differentiation IV

Project description:NR2F2 controls malignant squamous cell carcinoma state by promoting stemness and invasion and repressing differentiation IV

| PRJNA733353 | ENA

NR2F2 is an essential regulator of malignant tumor state by promoting tumor stemness, invasion and repressing differentiation I

Project description:NR2F2 is an essential regulator of malignant tumor state by promoting tumor stemness, invasion and repressing differentiation I

| PRJNA691284 | ENA

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data